• Difficulty breathing or shortness of breath
• Wheezing sounds during breathing
• Sensation of tightness in the chest and airflow obstruction
• Presence of nasal polyps
• Symptoms associated with chronic sinus infection, including nasal discharge, congestion, and reduced sense of smell
• Elevated eosinophil levels in the bloodstream

Eosinophilic asthma (EA) shares symptoms with other respiratory conditions, notably chronic obstructive pulmonary disease (COPD), which can lead to misdiagnosis. Accurate diagnosis is crucial to differentiate EA from other illnesses, as the treatment approaches differ significantly. Recognizing EA early improves management outcomes, reduces the risk of respiratory damage, and enhances quality of life.

Diagnosing Eosinophilic Asthma
Unlike more common asthma types triggered by allergens like pollen, dust, or pet dander, EA's roots are less understood. The precise cause remains elusive, but it is characterized by an abnormally high presence of eosinophils—white blood cells involved in allergic reactions and inflammation—in the blood and airway tissues.

To confirm EA and rule out other severe respiratory conditions, pulmonologists employ a series of diagnostic tests, including:

• Corticosteroid responsiveness tests to observe changes in respiratory function
• Blood tests measuring eosinophile counts
• Bronchial biopsy to analyze airway tissue samples

These assessments help determine the severity and specific characteristics of the condition, guiding appropriate treatment strategies.

Managing and Treating Eosinophilic Asthma
The primary treatment for EA usually involves inhalers—both for quick relief during attacks and maintenance. Inhaled corticosteroids are the cornerstone of controlling airway inflammation. However, some patients may not respond adequately to conventional therapies, necessitating alternative approaches aimed at reducing eosinophilic inflammation.

Effective control of inflammation is vital to prevent frequent exacerbations and long-term lung damage. The goal is to minimize airway swelling, which reduces symptom severity and the likelihood of attacks.

Alternative and Adjunctive Treatment Options

• Corticosteroid Therapy: While inhaled corticosteroids are standard, oral corticosteroids might be prescribed for severe cases. These are potent anti-inflammatory agents, but prolonged use can cause side effects like osteoporosis, weight gain, or immune suppression. Careful monitoring and dosage management by healthcare providers are essential.
• Biologic Agents: Recent advancements have introduced biologic therapies that target specific pathways involved in eosinophil activation. Drugs such as anti-IL-5 or anti-IL-5 receptor antibodies help decrease eosinophil levels, effectively reducing inflammation. These are administered via injections or infusion and are often reserved for refractory cases.
• Leukotriene Receptor Antagonists: These medications inhibit leukotrienes—chemical mediators that promote inflammation and airway constriction. By blocking their effects, these drugs help control symptoms and reduce airway inflammation.
• Rescue Inhalers: Fast-acting bronchodilators provide immediate relief during acute flare-ups. However, in EA patients, reliance on rescue inhalers should be minimized as excessive use may indicate poorly controlled disease.

Possible Complications of Uncontrolled EA
If eosinophilic asthma is not managed properly, it can lead to irreversible damage to the respiratory tissues. Chronic inflammation may cause scarring, airway remodeling, and diminished lung capacity. This can result in persistent respiratory difficulties despite treatment. Early intervention and consistent management are crucial to prevent these adverse outcomes.

Additionally, untreated EA can be associated with other health issues such as:

• Inner ear infections leading to balance problems
• Persistent sinus infections causing facial pain and congestion
• Aspirin-exacerbated respiratory disease (AERD), a complex condition involving sensitivity to aspirin and other NSAIDs
• Nasal polyps that can obstruct airflow and contribute to sinus symptoms
• Gastrointestinal eosinophilic diseases like eosinophilic gastroenteritis (EG) and eosinophilic enteritis (EE), which affect digestive health

The key to managing eosinophilic asthma is a comprehensive, ongoing treatment plan tailored to individual needs. This involves not only medication adherence but also lifestyle modifications such as regular exercise, a balanced diet rich in anti-inflammatory foods, sufficient rest, and avoiding environmental irritants. Creating a partnership with healthcare providers ensures optimal control, reducing the risk of complications and improving life quality.